Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation

Author:

Hutcheson Katherine A.1,Barrow Martha P.1,Barringer Denise A.1,Knott Jodi K.1,Lin Heather Y.2,Weber Randal S.1,Fuller Clifton D.3ORCID,Lai Stephen Y.1,Alvarez Clare P.1,Raut Janhavi4,Lazarus Cathy L.5,May Annette6,Patterson Joanne78,Roe Justin W. G.91011,Starmer Heather M.12,Lewin Jan S.1

Affiliation:

1. Department of Head and Neck Surgery; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston Texas

3. Department of Radiation Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

4. University of Texas Health Science Center, School of Public Health; Houston Texas

5. Department of Otolaryngology; Icahn School of Medicine at Mount Sinai; New York New York

6. Department of Oncology Speech Pathology; University of Florida Health Cancer Center-Orlando Health; Orlando Florida

7. Speech and Language Therapy Department; Sunderland City Hospitals National Health Service Foundation Trust; Sunderland United Kingdom

8. Institute of Health and Society; University of Newcastle; Newcastle Upon Tyne United Kingdom

9. Therapies Department; Royal Marsden National Health Service Foundation Trust; London United Kingdom

10. Speech and Language Therapy Department; Imperial College Healthcare National Health Service Trust; London United Kingdom

11. Department of Surgery and Cancer; Imperial College; London United Kingdom

12. Head and Neck Surgery, Department of Otolaryngology; Stanford University; Palo Alto California

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV) positive oropharyngeal cancer;Owadally;BMC Cancer.,2015

2. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)-study protocol for a randomized phase II trial;Nichols;BMC Cancer.,2013

3. NRG Oncology https://clinicaltrials.gov/ct2/show/NCT02254278 2016

4. Eastern Cooperative Oncology Group Transoral surgery followed by low-dose or standard-dose radiation therapy with or without chemotherapy in treating patients with HPV positive stage III-IVA oropharyngeal cancer https://clinicaltrials.gov/ct2/show/NCT01898494 2016

5. Institute of Cancer Research A phase III, randomised, multicentre study of dysphagia optimised intensity modulated radiotherapy (Do-IMRT) versus standard intensity modulated radiotherapy (S-IMRT) in head and neck cancer http://www.icr.ac.uk/our-research/our-research-centres/clinical-trials-and-statistics-unit/clinical-trials/dars 2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3